Key points/ Highlights
- Pulse rate in both groups reduced significantly compared to the
baseline values (P<0.005).
- In the intervention group, diastolic blood pressure reduced
significantly (P=0.023) but not in the control group (P=.162).
- Mean SO2 reduced in both groups, while in the
intervention group, the level of SO2 was higher.
Moreover, PLT significantly increased in the intervention group
(P=0.001).
- GCS significantly reduced in the control group from 14.85 to 11.62
(P=0.001).
- Hospitalization days were lower in the intervention group compared to
the control group (7.02 vs. 10.83 days) (P=0.001).
- Sputum, headache, dyspnea, chest discomfort, body pain, weakness and
fatigue, anorexia, anosmia, diarrhea, CVD, drug history, similar
symptoms in close relatives, fever, and chills, the two groups were
significantly different (P<0.05).
- 32% in the control group and 4% in the intervention group were
expired (P<0.001, odds ratio=0.08).
- CT score, 1 out 13 severe patients (7.7%) expired in the intervention
group while 20 out 28 severe patients (71.4%) expired in the control
group.
- Eight patients in the intervention group and 12 patients in the
control group required readmission, which this difference was not
significant (p=0.497).